An Open Label Study of Severe Sepsis in Adults
NCT00568893 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 130
Last updated 2007-12-06
Summary
This trial is to obtain safety data in adult patients with severe sepsis and two sepsis-induced organ infections who receive an infusion of drotrecogin alfa (activated).
Conditions
- Severe Sepsis
Interventions
- DRUG
-
drotrecogin alfa (activated)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Completion
- 2003-10-31
Countries
- Belgium
Study Locations
More Related Trials
-
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
NCT00604214 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis
NCT01486524 ·Status: UNKNOWN
-
A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis
NCT00034476 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study the Impact of Statins in Septic Shock
NCT02681653 ·Status: COMPLETED ·Phase: NA
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
Angiotensin in Septic Kidney Injury Trial
NCT00711789 ·Status: UNKNOWN ·Phase: PHASE2
-
Prevention of Sepsis-related Organ Dysfunction With Allocetra-OTS
NCT03925857 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
NCT07215702 ·Status: RECRUITING ·Phase: PHASE2
-
GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
NCT00089986 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic Shock
NCT01145560 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
NCT01598831 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Diagnosis and Risk Stratification of Sepsis
NCT01905033 ·Status: UNKNOWN
-
Microcirculation Guided Therapy Versus "Standard Treatment" of Severe Sepsis
NCT00484133 ·Status: UNKNOWN ·Phase: PHASE4
-
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock
NCT06746753 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Adrenomedullin and Outcome in Severe Sepsis and Septic Shock
NCT02393781 ·Status: COMPLETED
-
Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis
NCT00430859 ·Status: COMPLETED ·Phase: PHASE2
-
Statins for the Early Treatment of Sepsis
NCT00528580 ·Status: TERMINATED ·Phase: PHASE2
-
Angiotensin II Antagonist in Severe Sepsis
NCT01992796 ·Status: UNKNOWN ·Phase: PHASE3
-
Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic Shock
NCT01612676 ·Status: COMPLETED ·Phase: PHASE2
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
NCT04612413 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of COVID-19 Patients With Anti-interleukin Drugs
NCT04330638 ·Status: COMPLETED ·Phase: PHASE3
-
Epirubicin for the Treatment of Sepsis & Septic Shock
NCT05033808 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis
NCT00493415 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious Infection
NCT01025180 ·Status: TERMINATED ·Phase: PHASE4